Irritable Bowel Syndrome Trial, Recruiting (NCT06912828)

Irritable Bowel Syndrome Trial, Recruiting NCT06912828 Sponsor: Attikon Hospital Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06912828 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) based on a standard set of recognised diagnostic guidelines called the Rome IV criteria
You are willing and able to sign a consent form agreeing to take part in the study
You are able to commit to being available and participating for the full duration of the study
Your IBS symptoms are above a certain level of severity, measured by a score greater than 175 on a standard IBS symptom rating scale (confirm with trial site)

Who may not be able to join:

You have another health condition that requires you to follow a special diet, such as kidney failure, diabetes, coeliac disease, a brain or nervous system condition, or if you have had major surgery affecting your digestive system
You are currently pregnant
You are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +306977402690

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06912828

Sponsor: Attikon Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: +306977402690

More information: https://clinicaltrials.gov/study/NCT06912828

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) based on a standard set of recognised diagnostic guidelines called the Rome IV criteria
You are willing and able to sign a consent form agreeing to take part in the study
You are able to commit to being available and participating for the full duration of the study
Your IBS symptoms are above a certain level of severity, measured by a score greater than 175 on a standard IBS symptom rating scale (confirm with trial site)

Who may not be able to join:

You have another health condition that requires you to follow a special diet, such as kidney failure, diabetes, coeliac disease, a brain or nervous system condition, or if you have had major surgery affecting your digestive system
You are currently pregnant
You are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Attikon Hospital

Registry

ClinicalTrials.gov

Start date

15 September 2024

Est. completion

15 September 2026

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Find single nucleotide polymorphisms (SNPs) that associate with the diet respone

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov